1. Home
  2. ELVN vs ALM Comparison

ELVN vs ALM Comparison

Compare ELVN & ALM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • ALM
  • Stock Information
  • Founded
  • ELVN 2016
  • ALM N/A
  • Country
  • ELVN United States
  • ALM Canada
  • Employees
  • ELVN N/A
  • ALM N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • ALM Other Metals and Minerals
  • Sector
  • ELVN Health Care
  • ALM Basic Materials
  • Exchange
  • ELVN Nasdaq
  • ALM Nasdaq
  • Market Cap
  • ELVN 1.2B
  • ALM 958.4M
  • IPO Year
  • ELVN 2020
  • ALM N/A
  • Fundamental
  • Price
  • ELVN $19.02
  • ALM $4.88
  • Analyst Decision
  • ELVN Strong Buy
  • ALM Strong Buy
  • Analyst Count
  • ELVN 5
  • ALM 2
  • Target Price
  • ELVN $41.20
  • ALM $7.00
  • AVG Volume (30 Days)
  • ELVN 489.5K
  • ALM 715.6K
  • Earning Date
  • ELVN 11-12-2025
  • ALM 08-14-2025
  • Dividend Yield
  • ELVN N/A
  • ALM N/A
  • EPS Growth
  • ELVN N/A
  • ALM N/A
  • EPS
  • ELVN N/A
  • ALM N/A
  • Revenue
  • ELVN N/A
  • ALM $20,657,545.00
  • Revenue This Year
  • ELVN N/A
  • ALM $143.16
  • Revenue Next Year
  • ELVN $20.05
  • ALM $126.76
  • P/E Ratio
  • ELVN N/A
  • ALM N/A
  • Revenue Growth
  • ELVN N/A
  • ALM 9.87
  • 52 Week Low
  • ELVN $13.30
  • ALM $3.16
  • 52 Week High
  • ELVN $30.03
  • ALM $5.50
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 44.06
  • ALM 60.33
  • Support Level
  • ELVN $18.01
  • ALM $4.45
  • Resistance Level
  • ELVN $20.30
  • ALM $5.04
  • Average True Range (ATR)
  • ELVN 1.11
  • ALM 0.27
  • MACD
  • ELVN -0.16
  • ALM 0.07
  • Stochastic Oscillator
  • ELVN 30.70
  • ALM 84.91

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About ALM Almonty Industries Inc. Common Shares

Almonty Industries Inc is engaged in the mining, processing, and shipping of tungsten concentrate from its Los Santos tungsten mine located near Salamanca, Spain - the Los Santos Mine, the processing and shipping of tungsten concentrate from its Panasqueira tin and tungsten mine in Covilha, Castelo Branco, Portugal - the Panasqueira Mine, the evaluation of its Valtreixal tin and tungsten mine project located in Western Spain in the province of Zamora - the Valtreixal Mine, as well as the exploration and evaluation of its Sangdong tungsten mine project located in Gangwon Province, Republic of Korea - the Sangdong Mine.

Share on Social Networks: